TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 651.3M
Gross Profit 116.5M 17.89%
Operating Income -24.8M -3.81%
Net Income -562.9M -86.43%
EPS (Diluted) $-6.25

Balance Sheet Metrics

Total Assets 3.1B
Total Liabilities 2.3B
Shareholders Equity 858.8M
Debt to Equity 2.63

Cash Flow Metrics

Operating Cash Flow -620.6M
Free Cash Flow -127.1M

Revenue & Profitability Trend

Fortrea Holdings Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i2.7B3.1B3.1B3.1B2.6B
Cost of Goods Sold i2.2B2.6B2.4B2.5B2.1B
Gross Profit i534.2M520.4M648.7M604.4M489.1M
Gross Margin % i19.8%16.7%21.0%19.8%19.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i560.7M336.6M279.8M303.1M267.6M
Other Operating Expenses i-----
Total Operating Expenses i560.7M336.6M279.8M303.1M267.6M
Operating Income i-111.8M87.4M276.2M135.0M102.5M
Operating Margin % i-4.1%2.8%8.9%4.4%4.0%
Non-Operating Items
Interest Income i-----
Interest Expense i123.8M69.8M200.0K200.0K-
Other Non-Operating Income-39.4M-16.5M-39.0M1.6M-434.7M
Pre-tax Income i-275.0M1.1M237.0M136.4M-332.2M
Income Tax i-3.5M4.5M44.1M38.4M27.0M
Effective Tax Rate % i0.0%409.1%18.6%28.2%0.0%
Net Income i-328.5M-3.4M192.9M98.0M-359.2M
Net Margin % i-12.2%-0.1%6.2%3.2%-13.9%
Key Metrics
EBITDA i-3.6M190.7M371.1M303.4M657.0M
EPS (Basic) i$-3.67$-0.04$2.18$1.11$-4.06
EPS (Diluted) i$-3.67$-0.04$2.18$1.11$-4.06
Basic Shares Outstanding i8950953788800000884000008840000088400000
Diluted Shares Outstanding i8950953788800000884000008840000088400000

Income Statement Trend

Fortrea Holdings Balance Sheet From 2021 to 2024

Metric2024202320222021
Assets
Current Assets
Cash & Equivalents i118.5M108.6M112.0M94.6M
Short-term Investments i----
Accounts Receivable i156.5M481.0M449.2M422.5M
Inventory i----
Other Current Assets77.2M35.1M50.8M73.1M
Total Current Assets i948.2M1.3B1.2B1.1B
Non-Current Assets
Property, Plant & Equipment i66.2M78.2M50.0M65.7M
Goodwill i4.1B4.8B4.8B5.1B
Intangible Assets i655.7M771.2M823.3M935.5M
Long-term Investments----
Other Non-Current Assets108.6M82.7M55.5M72.2M
Total Non-Current Assets i2.6B3.1B3.0B3.3B
Total Assets i3.6B4.4B4.3B4.4B
Liabilities
Current Liabilities
Accounts Payable i138.2M132.8M81.5M60.5M
Short-term Debt i88.2M45.6M23.3M24.0M
Current Portion of Long-term Debt----
Other Current Liabilities39.0M36.0M27.1M30.2M
Total Current Liabilities i949.5M775.9M699.0M826.7M
Non-Current Liabilities
Long-term Debt i1.1B1.6B40.1M53.2M
Deferred Tax Liabilities i121.7M148.8M184.5M210.3M
Other Non-Current Liabilities35.3M61.3M21.7M17.9M
Total Non-Current Liabilities i1.3B1.8B246.3M281.4M
Total Liabilities i2.2B2.6B945.3M1.1B
Equity
Common Stock i100.0K100.0K0-
Retained Earnings i-397.0M-49.1M0-
Treasury Stock i----
Other Equity----
Total Shareholders Equity i1.4B1.7B3.3B3.3B
Key Metrics
Total Debt i1.2B1.7B63.4M77.2M
Working Capital i-1.3M477.2M547.9M290.8M

Balance Sheet Composition

Fortrea Holdings Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-328.5M-3.4M192.9M98.0M-359.2M
Depreciation & Amortization i86.9M96.4M92.7M166.3M119.0M
Stock-Based Compensation i58.4M42.7M25.4M27.5M23.1M
Working Capital Changes i457.1M18.9M-115.1M-154.2M-28.3M
Operating Cash Flow i272.6M140.5M208.4M142.8M-242.0M
Investing Activities
Capital Expenditures i-----
Acquisitions i276.6M-00-137.5M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i277.1M8.5M400.0K300.0K-137.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i826.5M1.8B00-
Debt Repayment i-1.3B-179.4M00-
Financing Cash Flow i-497.8M-139.0M-8.7M-128.5M-33.1M
Free Cash Flow i237.3M127.1M33.1M143.3M176.9M
Net Change in Cash i51.9M10.0M200.1M14.6M-412.3M

Cash Flow Trend

Fortrea Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 522.33
Forward P/E 7.81
Price to Book 1.58
Price to Sales 0.34
PEG Ratio 3.13

Profitability Ratios

Profit Margin -37.57%
Operating Margin -1.54%
Return on Equity -100.49%
Return on Assets -1.42%

Financial Health

Current Ratio 1.02
Debt to Equity 210.86
Beta 1.89

Per Share Data

EPS (TTM) $-11.39
Book Value per Share $6.49
Revenue per Share $30.36

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ftre932.8M522.331.58-100.49%-37.57%210.86
Vertex 101.2B28.085.8922.77%31.86%8.89
Alnylam 61.1B-213.71244.95-257.83%-12.96%1,093.31
Adaptive 1.9B-11.6810.68-57.60%-59.07%121.39
Dyne Therapeutics 1.9B-3.902.63-61.32%0.00%21.19
Harmony Biosciences 1.9B10.452.4127.58%23.42%22.43

Financial data is updated regularly. All figures are in the company's reporting currency.